The Herpesviruses: The Viruses
Editat de Bernard Roizmanen Limba Engleză Paperback – 26 apr 2013
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (3) | 367.91 lei 6-8 săpt. | |
Springer Us – 27 sep 2011 | 367.91 lei 6-8 săpt. | |
Springer Us – 26 apr 2013 | 369.65 lei 6-8 săpt. | |
Springer Us – 8 apr 2012 | 703.09 lei 6-8 săpt. |
Din seria The Viruses
- 5% Preț: 1366.62 lei
- 5% Preț: 1076.55 lei
- 5% Preț: 1377.85 lei
- 5% Preț: 1379.99 lei
- 18% Preț: 924.21 lei
- 5% Preț: 2055.46 lei
- 5% Preț: 365.26 lei
- 5% Preț: 379.70 lei
- Preț: 385.22 lei
- 15% Preț: 628.46 lei
- 5% Preț: 713.98 lei
- 5% Preț: 364.02 lei
- 5% Preț: 367.56 lei
- 5% Preț: 821.47 lei
- Preț: 376.90 lei
- 5% Preț: 697.12 lei
- 5% Preț: 370.36 lei
- 5% Preț: 357.70 lei
- 5% Preț: 368.78 lei
- Preț: 377.83 lei
- 5% Preț: 713.48 lei
- 5% Preț: 376.51 lei
- 15% Preț: 628.31 lei
- 5% Preț: 698.70 lei
Preț: 369.65 lei
Preț vechi: 389.11 lei
-5% Nou
Puncte Express: 554
Preț estimativ în valută:
70.75€ • 74.38$ • 58.85£
70.75€ • 74.38$ • 58.85£
Carte tipărită la comandă
Livrare economică 27 decembrie 24 - 10 ianuarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9781468441659
ISBN-10: 1468441655
Pagini: 464
Ilustrații: XV, 445 p. 72 illus.
Dimensiuni: 178 x 254 x 24 mm
Greutate: 0.8 kg
Ediția:1982
Editura: Springer Us
Colecția Springer
Seria The Viruses
Locul publicării:New York, NY, United States
ISBN-10: 1468441655
Pagini: 464
Ilustrații: XV, 445 p. 72 illus.
Dimensiuni: 178 x 254 x 24 mm
Greutate: 0.8 kg
Ediția:1982
Editura: Springer Us
Colecția Springer
Seria The Viruses
Locul publicării:New York, NY, United States
Public țintă
ResearchCuprins
1 The Family Herpesviridae: General Description, Taxonomy, and Classification.- I. Description of the Family.- II. Naming of Herpesviruses.- III. Classification of Herpesviruses.- References.- 2 Epidemiology of Epstein—Barr Virus and Associated Diseases in Man.- I. Province of Epidemiology.- II. Natural History of Epstein-Barr Virus.- III. Disease Associated with Primary Infection by Epstein-Barr Virus: Infectious Mononucleosis.- IV. Role of Epstein-Barr Virus in the Pathogenesis of Burkitt Lymphoma.- VI. Summary and Conclusions.- References.- 3 Biochemistry of Epstein—Barr Virus.- I. Introduction.- II. Structural Components of the Virus.- III. Transformation and Latency within B Lymphocytes.- IV. Abortive and Productive Infection.- V. Summary.- References.- 4 Biology of Lymphoid Cells Transformed by Epstein—Barr Virus.- I. Establishment of Lymphoblastoid-Cell Lines from Patients.- II. Establishment of Lymphoblastoid-Cell Lines by in Vitro Transformation.- III. Surface of Epstein-Barr-Virus-Transformed Cells.- IV. Immunoglobulin Synthesis by Epstein-Barr-Virus Transformed Cells.- V. Morphology and Growth Characteristics.- VI. Epstein-Barr Viral Genome Expression in Transformed Cells.- References.- 5 Immunology of Epstein—Barr Virus.- I. Introduction.- II. Epstein-Barr-Virus-Specific Antigens.- III. Epstein-Barr-Virus-Specific Immune Responses.- IV. Concluding Remarks.- References.- 6 Herpesvirus saimiri and Herpesvirus ateles.- I. Introduction.- II. Natural History of Oncogenic Herpesviruses from New World Primates.- III. Structure, Composition, and Replication of Virus Particles.- IV. Classification of Oncogenic Primate Herpesviruses.- V. Pathology of Neoplastic Diseases caused by Herpesvirus saimiri and Herpesvirus ateles.- VI. Mechanisms of Pathogenesis inOncogenic Transformation and Tumor Induction.- VII. Concluding Remarks.- References.- 7 The Molecular Biology of Marek’s Disease Herpesvirus.- I. Introduction.- II. Marek’s Disease Virus Deoxyribonucleic Acid.- III. Proteins.- IV. Marek’s Disease Virus Genome Expression.- V. Comparison of Lymphoblastoid Cells Transformed by Marek’s Disease Virus with Those Transformed by Epstein-Barr Virus.- References.- 8 Biology of Marek’s Disease Virus and the Herpesvirus of Turkeys.- I. Introduction.- II. Historical Considerations.- III. Natural Occurrence.- IV. Virology.- V. Pathology.- VI. Host Genetics.- VII. Immunology.- VIII. Epizootiology.- IX. Control of Marek’s Disease.- X. Concluding Remarks.- References.